Lamotrigine is best known as a mood stabiliser for bipolar depression and as an anticonvulsant for partial seizures. In schizophrenia it occupies a smaller but interesting niche: as a possible augmenting agent for clozapine when symptoms remain stubborn, and as a mood stabiliser for schizoaffective disorder, particularly the depressive subtype. The evidence is more limited than for some other mood stabilisers, but for the right patient it can be genuinely useful.
Lamotrigine is a sodium-channel-blocking anticonvulsant that may help some patients with clozapine-resistant schizophrenia and is often used in schizoaffective disorder for its antidepressant and mood-stabilising effects.
How it works
Lamotrigine inhibits voltage-gated sodium channels and reduces glutamate release in the brain. The glutamate effect is particularly relevant to schizophrenia, because abnormalities in glutamate signalling — especially through NMDA receptors — are increasingly thought to contribute to psychotic symptoms. This theoretical basis is part of why lamotrigine has been studied as an augmenting agent.
The clozapine augmentation evidence
Clozapine is the most effective antipsychotic available, but a meaningful minority of patients still have residual symptoms even on optimised clozapine. Lamotrigine has been studied as an add-on in this scenario, and several small studies and meta-analyses have suggested modest improvements in positive symptoms when added to clozapine.
The effect sizes are moderate at best, and not every patient responds. But because the alternatives for ultra-resistant schizophrenia are limited, lamotrigine remains in many treatment algorithms as a reasonable option to try. See our pieces on clozapine and recovery after clozapine for context on this population.
Schizoaffective disorder, depressive type
Lamotrigine is particularly well-supported for the depressive pole of bipolar disorder. In schizoaffective disorder, depressive type, where psychotic symptoms coexist with major depressive episodes, lamotrigine is often used alongside an antipsychotic. The combination targets both axes of the illness without the metabolic burden of adding another antipsychotic.
Typical dosing
Lamotrigine has the most cautious titration of any commonly used psychiatric medication, because rapid escalation increases the risk of serious skin reactions:
- Weeks 1–2: 25 mg daily
- Weeks 3–4: 50 mg daily
- Week 5: 100 mg daily
- Week 6 onwards: 200 mg daily, the typical maintenance target
If valproate is also being taken, lamotrigine is titrated even more slowly, and the target dose is roughly halved, because valproate raises lamotrigine levels significantly. Carbamazepine and some other inducers do the opposite.
The rash you need to take seriously
You develop any rash within the first 8 weeks, particularly one with fever, blistering, mucous membrane involvement (mouth, eyes, genitals), or peeling skin. These can signal Stevens-Johnson syndrome or toxic epidermal necrolysis — rare but life-threatening.
Most lamotrigine-associated rashes are mild and benign, but the small risk of severe rash is the main reason for the slow titration. The risk is highest in the first 8 weeks, in patients younger than 16, and when valproate is co-prescribed without dose adjustment.
Other side effects
- Headache
- Dizziness
- Nausea
- Insomnia or vivid dreams
- Mild tremor
- Diplopia (double vision) — usually with higher doses
- Rarely, hypersensitivity syndrome (DRESS) — fever, rash, organ involvement
- Rarely, hemophagocytic lymphohistiocytosis (HLH) — extremely rare, FDA warning issued in 2018
Compared to other mood stabilisers, lamotrigine is unusually weight-neutral and has a generally tolerable side effect profile if the rash window is navigated safely.
Drug interactions worth understanding
- Valproate: doubles lamotrigine levels — lamotrigine dose must be reduced
- Carbamazepine, phenytoin, phenobarbital: lower lamotrigine levels
- Combined oral contraceptives (estrogen): lower lamotrigine levels — patients may need dose adjustments when starting or stopping the pill
- Pregnancy: lamotrigine levels often drop substantially in pregnancy and need close monitoring
What lamotrigine is not very good at
Lamotrigine is not effective for acute mania. It is also not effective on its own for primary positive psychotic symptoms in schizophrenia. It will not replace an antipsychotic. It is, at best, a thoughtful addition.
Pregnancy
Lamotrigine has a relatively reassuring pregnancy safety profile compared to valproate, with most large registries showing no significant increase in major malformations. It is one of the more commonly used psychiatric medications in pregnancy, but levels need monitoring.
Practical questions
- Specifically what symptom are we hoping to improve with lamotrigine?
- What is the titration plan, and how should I report any rash?
- How long is a fair trial before deciding it is or isn't helping?
- Are any of my other medications going to interact?
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.